FindTrial
Sign In

Study on the application value of cytokine level monitoring in the observation of the efficacy and prognosis of psoriasis biologics

Study on the application value of cytokine level monitoring in the observation of the efficacy and prognosis of psoriasis biologics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092726
Enrollment
Unknown
Registered
2024-11-21
Start date
2024-12-01
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis

Interventions

Biologics treatment group:NA
Conventional treatment group:NA

Sponsors

The First Affiliated Hospital of Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The patient was diagnosed as "psoriasis" (vulgaris, erythroderma, joint, pustular) in the dermatology department of the First Affiliated Hospital of Xi 'an Jiaotong University. 2. Patients receiving biologics have completed at least the induction period (intensive injection period), and patients receiving conventional treatment have been treated for at least 2 months.

Exclusion criteria

Exclusion criteria: 1. Medical records show that patients with infectious diseases, immune system diseases, blood system diseases, connective tissue diseases and other related important organ diseases. 2. Medical records indicate pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Cytokines level;—

Countries

China

Contacts

Public ContactWang Jingyuan

The First Affiliated Hospital of Xi'an Jiaotong University

123436110@qq.com+86 18049661468

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026